OpenURL Connection Search

Select item for more details and to access through your institution.

Use of calcipotriene cream (DOVONEX Cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (TACLONEX): a randomized, parallel-group clinical trial.
Published in:
2006
By:
- White S;
- Vender R;
- Thaçi D;
- Haverkamp C;
- Naeyaert J;
- Foster R;
- Martinez Escribano JA;
- Cambazard F;
- Bibby A
Publication type:
Journal Article
Qualität der dermatologischen Versorgung von Neurodermitis in Deutschland – keine Verbesserung der Indikatoren nach 10 Jahren.
Published in:
Der Hautarzt, 2021, v. 72, n. 12, p. 1079, doi. 10.1007/s00105-021-04885-3
By:
- Langenbruch, A.;
- Mohr, N.;
- Abeck, F.;
- Schmitt, J.;
- Ständer, S.;
- Werfel, T.;
- Thaçi, D.;
- Weidinger, S.;
- Augustin, M.
Publication type:
Article
Psoriasis und Mikrobiom.
Published in:
Der Hautarzt, 2019, v. 70, n. 6, p. 416, doi. 10.1007/s00105-019-4415-7
By:
- Witte, M.;
- Thaçi, D.
Publication type:
Article
Psoriasisarthritis.
Published in:
Der Hautarzt, 2017, v. 68, n. 2, p. 153, doi. 10.1007/s00105-016-3925-9
By:
- Behrens, F.;
- Thaçi, D.;
- Wollenhaupt, J.;
- Krüger, K.
Publication type:
Article
Topische Antibiotika zur Therapie von Hautinfektionen.
Published in:
Der Hautarzt, 2005, v. 56, n. 4, p. 381, doi. 10.1007/s00105-005-0935-4
By:
- Thaçi, D.;
- Schöfer, H.
Publication type:
Article
Langzeitmanagement des atopischen Ekzems bei Kindern mit Calcineurininhibitoren.
Published in:
Der Hautarzt, 2003, v. 54, n. 5, p. 418
By:
- Dr. D. Thaçi
Publication type:
Article
The German National Program on Psoriasis Health Care 2005-2015: results and experiences.
Published in:
Archives of Dermatological Research, 2016, v. 308, n. 6, p. 389, doi. 10.1007/s00403-016-1637-8
By:
- Augustin, M.;
- Eissing, L.;
- Langenbruch, A.;
- Enk, A.;
- Luger, T.;
- Maaßen, D.;
- Mrowietz, U.;
- Reich, K.;
- Reusch, M.;
- Strömer, K.;
- Thaçi, D.;
- Kiedrowski, R.;
- Radtke, M.
Publication type:
Article
Direct comparison of risankizumab and fumaric acid esters in systemic therapy–naïve patients with moderate‐to‐severe plaque psoriasis: a randomized controlled trial*.
Published in:
British Journal of Dermatology, 2022, v. 186, n. 1, p. 30, doi. 10.1111/bjd.20481
By:
- Thaçi, D.;
- Eyerich, K.;
- Pinter, A.;
- Sebastian, M.;
- Unnebrink, K.;
- Rubant, S.;
- Williams, D. A.;
- Weisenseel, P.
Publication type:
Article
Association of sex and systemic therapy treatment outcomes in psoriasis: a two‐country, multicentre, prospective, noninterventional registry study*.
Published in:
British Journal of Dermatology, 2021, v. 185, n. 6, p. 1160, doi. 10.1111/bjd.20387
By:
- Maul, J.‐T.;
- Augustin, M.;
- Sorbe, C.;
- Conrad, C.;
- Anzengruber, F.;
- Mrowietz, U.;
- Reich, K.;
- French, L.E.;
- Radtke, M.;
- Häusermann, P.;
- Maul, L.V.;
- Boehncke, W.‐H.;
- Thaçi, D.;
- Navarini, A.A.
Publication type:
Article
Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study
Published in:
British Journal of Dermatology, 2021, v. 184, n. 5, p. 857, doi. 10.1111/bjd.19460
By:
- Cork, M.J.;
- Thaçi, D.;
- Eichenfield, L.F.;
- Arkwright, P.D.;
- Sun, X.;
- Chen, Z.;
- Akinlade, B.;
- Boklage, S.;
- Guillemin, I.;
- Kosloski, M.P.;
- Kamal, M.A.;
- O'Malley, J.T.;
- Patel, N.;
- Graham, N.M.H.;
- Bansal, A.
Publication type:
Article
Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2).
Published in:
British Journal of Dermatology, 2021, v. 184, n. 4, p. 652, doi. 10.1111/bjd.19393
By:
- Gordon, K.B.;
- Warren, R.B.;
- Gottlieb, A.B.;
- Blauvelt, A.;
- Thaçi, D.;
- Leonardi, C.;
- Poulin, Y.;
- Boehnlein, M.;
- Brock, F.;
- Ecoffet, C.;
- Reich, K.
Publication type:
Article
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment.
Published in:
British Journal of Dermatology, 2021, v. 184, n. 3, p. 548, doi. 10.1111/bjd.19558
By:
- Leutz, A.;
- Pinter, A.;
- Thaçi, D.;
- Augustin, M.;
- Schuster, C.;
- Fotiou, K.;
- Hundemer, H.P.;
- Saure, D.;
- Mrowietz, U.;
- Reich, K.
Publication type:
Article
Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS).
Published in:
British Journal of Dermatology, 2020, v. 183, n. 2, p. 265, doi. 10.1111/bjd.18696
By:
- Thaçi, D.;
- Pinter, A.;
- Sebastian, M.;
- Termeer, C.;
- Sticherling, M.;
- Gerdes, S.;
- Wegner, S.;
- Krampe, S.;
- Bartz, H.;
- Rausch, C.;
- Mensch, A.;
- Eyerich, K.
Publication type:
Article
Management of Psoriasis in Africa and the Middle East: a Review of Current Opinion, Practice and Opportunities for Improvement.
Published in:
Journal of International Medical Research, 2011, v. 39, n. 5, p. 1573, doi. 10.1177/147323001103900501
By:
- ABDULGHANI, M.;
- AL SHEIK, A.;
- ALKHAWAJAH, M.;
- AMMOURY, A.;
- BEHRENS, F.;
- BENCHIKHI, H.;
- BENKAIDALI, I.;
- DOSS, N.;
- EL GENDY, A.;
- MOKHTAR, I.;
- ODENDAAL, D.;
- RABOOBEE, N.;
- THAÇI, D.;
- WEISS, R.;
- WHITAKER, D.
Publication type:
Article
Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2012, v. 26, n. 4, p. 448, doi. 10.1111/j.1468-3083.2011.04093.x
By:
- Paul, C.;
- Stalder, J.F.;
- Thaçi, D.;
- Vincendon, P.;
- Brault, Y.;
- Kielar, D.;
- Tebbs, V.
Publication type:
Article
Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2011, v. 25, n. 10, p. 1187, doi. 10.1111/j.1468-3083.2010.03947.x
By:
- Boehncke, S.;
- Salgo, R.;
- Garbaraviciene, J.;
- Beschmann, H.;
- Hardt, K.;
- Diehl, S.;
- Fichtlscherer, S.;
- Thaçi, D.;
- Boehncke, W.-H.
Publication type:
Article
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2011, v. 25, n. 9, p. 1012, doi. 10.1111/j.1468-3083.2010.03944.x
By:
- Ortonne, J.-P.;
- Chimenti, S.;
- Reich, K.;
- Gniadecki, R.;
- Sprøgel, P.;
- Unnebrink, K.;
- Kupper, H.;
- Goldblum, O.;
- Thaçi, D.
Publication type:
Article
Psoriasisarthritis.
Published in:
Zeitschrift für Rheumatologie, 2016, v. 75, n. 5, p. 471, doi. 10.1007/s00393-016-0110-6
By:
- Behrens, F.;
- Thaçi, D.;
- Wollenhaupt, J.;
- Krüger, K.
Publication type:
Article
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre‐specified patient subgroups in the Effisayil 1 study.
Published in:
Experimental Dermatology, 2023, v. 32, n. 8, p. 1279, doi. 10.1111/exd.14824
By:
- Burden, A. D.;
- Okubo, Y.;
- Zheng, M.;
- Thaçi, D.;
- van de Kerkhof, P.;
- Hu, N.;
- Quaresma, M.;
- Thoma, C.;
- Choon, S. E.
Publication type:
Article
Upadacitinib for moderate‐to‐severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 9, p. 1871, doi. 10.1111/jdv.19232
By:
- Thyssen, J. P.;
- Thaçi, D.;
- Bieber, T.;
- Gooderham, M.;
- de Bruin‐Weller, M.;
- Soong, W.;
- Kabashima, K.;
- Barbarot, S.;
- Luna, P. C.;
- Xu, J.;
- Hu, X.;
- Liu, Y.;
- Raymundo, E. M.;
- Calimlim, B. M.;
- Nduaka, C.;
- Gamelli, A.;
- Simpson, E. L.
Publication type:
Article
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 976, doi. 10.1111/jdv.18881
By:
- Bissonnette, R.;
- Eichenfield, L. F.;
- Simpson, E.;
- Thaçi, D.;
- Kabashima, K.;
- Thyssen, J. P.;
- Guttman‐Yassky, E.;
- Nunes, F. P.;
- Gamalo, M.;
- Ahmad, F.;
- Kuligowski, M.;
- Sun, K.;
- Pipper, C.;
- Christensen, A. W.;
- D'Angelo, P.;
- Milutinovic, M.;
- Guettner, A.;
- Silverberg, J. I.
Publication type:
Article
Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LONG.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 1, p. 60, doi. 10.1111/jdv.17673
By:
- Jalili, A.;
- Calzavara‐Pinton, P.;
- Kircik, L.;
- Lons‐Danic, D.;
- Pink, A.;
- Tyring, S.;
- de la Cueva, P.;
- Gooderham, M.;
- Segaert, S.;
- Nyholm, N.;
- Thoning, H.;
- Petersen, B.;
- Thaçi, D.
Publication type:
Article
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate‐to‐severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 11, p. e709, doi. 10.1111/jdv.17427
By:
- Thaçi, D.;
- Jullien, D.;
- Egeberg, A.;
- Carrascosa, J.M.;
- Wu, J.J.;
- Pau‐Charles, I.;
- Gisondi, P.
Publication type:
Article
Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 8, p. 1686, doi. 10.1111/jdv.17109
By:
- Thaçi, D.;
- Soliman, A.M.;
- Eyerich, K.;
- Pinter, A.;
- Sebastian, M.;
- Unnebrink, K.;
- Rubant, S.;
- Williams, D.A.;
- Weisenseel, P.
Publication type:
Article
Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti‐BP180 autoantibodies.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 4, p. 981, doi. 10.1111/jdv.17013
By:
- Ständer, S.;
- Schmidt, E.;
- Zillikens, D.;
- Thaçi, D.;
- Ludwig, R.J.;
- Kridin, K.
Publication type:
Article
Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, p. 35, doi. 10.1111/jdv.17053
By:
- Lebwohl, M.;
- Thaçi, D.;
- Warren, R.B.
Publication type:
Article
Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 12, p. 2809, doi. 10.1111/jdv.16433
By:
- Merola, J.F.;
- Papp, K.A.;
- Nash, P.;
- Gratacós, J.;
- Boehncke, W.H.;
- Thaçi, D.;
- Graham, D.;
- Hsu, M‐A.;
- Wang, C.;
- Wu, J.;
- Young, P.
Publication type:
Article
Alopecia areata development in atopic dermatitis patients treated with dupilumab.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 10, p. e612, doi. 10.1111/jdv.16493
By:
- Ständer, S.;
- Trense, Y.;
- Thaçi, D.;
- Ludwig, R.J.
Publication type:
Article
Secukinumab is effective in treatment of moderate‐to‐severe plaque psoriasis: real‐life effectiveness and safety from the PROSPECT study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 2, p. 310, doi. 10.1111/jdv.15962
By:
- Thaçi, D.;
- Körber, A.;
- Kiedrowski, R.;
- Bachhuber, T.;
- Melzer, N.;
- Kasparek, T.;
- Duetting, E.;
- Kraehn‐Senftleben, G.;
- Amon, U.;
- Augustin, M.
Publication type:
Article
Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 6, p. 1116, doi. 10.1111/jdv.15398
By:
- Pink, A.E.;
- Jalili, A.;
- Berg, P.;
- Calzavara‐Pinton, P.G.;
- Cueva Dobao, P.;
- Thaçi, D.;
- Torpet, M.;
- Jensen, K.L.;
- Segaert, S.
Publication type:
Article
Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 4, p. 709, doi. 10.1111/jdv.15393
By:
- Jalili, A.;
- Lebwohl, M.;
- Stein Gold, L.;
- Andersen, S.B.;
- Jensen, K.L.;
- Pink, A.E.;
- Segaert, S.;
- Berg, P.;
- Calzavara‐Pinton, P.G.;
- Cueva Dobao, P.;
- Thaçi, D.
Publication type:
Article
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).
Published in:
Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 9, p. 1507, doi. 10.1111/jdv.14878
By:
- Bissonnette, R.;
- Luger, T.;
- Thaçi, D.;
- Toth, D.;
- Lacombe, A.;
- Xia, S.;
- Mazur, R.;
- Patekar, M.;
- Charef, P.;
- Milutinovic, M.;
- Leonardi, C.;
- Mrowietz, U.
Publication type:
Article
Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque‐type psoriasis: 30‐week results from the phase 3, confirmatory EGALITY study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 3, p. 420, doi. 10.1111/jdv.14605
By:
- Gerdes, S.;
- Thaçi, D.;
- Griffiths, C. E. M.;
- Arenberger, P.;
- Poetzl, J.;
- Wuerth, G.;
- Afonso, M.;
- Woehling, H.
Publication type:
Article
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real‐life data of prior and concomitant use of psoriasis treatments from the PROSPECT study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 3, p. 411, doi. 10.1111/jdv.14604
By:
- Körber, A.;
- Thaçi, D.;
- Von Kiedrowski, R.;
- Bachhuber, T.;
- Melzer, N.;
- Kasparek, T.;
- Kraehn‐senftleben, G.;
- Amon, U.;
- Augustin, M.
Publication type:
Article
Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 3, p. 498, doi. 10.1111/jdv.13918
By:
- Thaçi, D.;
- Kimball, A.;
- Foley, P.;
- Poulin, Y.;
- Levi, E.;
- Chen, R.;
- Feldman, S.R.
Publication type:
Article
Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 2, p. 353, doi. 10.1111/jdv.12553
By:
- Thaçi, D.;
- Unnebrink, K.;
- Sundaram, M.;
- Sood, S.;
- Yamaguchi, Y.
Publication type:
Article
Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2014, v. 28, n. 7, p. 900, doi. 10.1111/jdv.12207
By:
- Thaçi, D.;
- Galimberti, R.;
- Amaya ‐ Guerra, M.;
- Rosenbach, T.;
- Robertson, D.;
- Pedersen, R.;
- Yang, S.;
- Kuligowski, M.;
- Boggs, R.
Publication type:
Article
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2013, v. 27, n. 3, p. e376, doi. 10.1111/j.1468-3083.2012.04716.x
By:
- Papp, K.A.;
- Kaufmann, R.;
- Thaçi, D.;
- Hu, C.;
- Sutherland, D.;
- Rohane, P.
Publication type:
Article
比较生物制剂依奇珠单抗与其他两种治疗银屑病的药物富马酸酯和甲氨蝶呤的试验
Published in:
British Journal of Dermatology, 2020, v. 182, n. 4, p. e148, doi. 10.1111/bjd.18915
By:
- Reich, K.;
- Augustin, M.;
- Thaçi, D.;
- Pinter, A.;
- Leutz, A.;
- Henneges, C.;
- Schneider, E.;
- Schacht, A.;
- Dossenbach, M.;
- Mrowietz, U.
Publication type:
Article
A trial to compare the biologic drug ixekizumab with two other treatments for psoraisis, fumaric acid esters and methotrexate.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 4, p. e138, doi. 10.1111/bjd.18905
By:
- Reich, K.;
- Augustin, M.;
- Thaçi, D.;
- Pinter, A.;
- Leutz, A.;
- Henneges, C.;
- Schneider, E.;
- Schacht, A.;
- Dossenbach, M.;
- Mrowietz, U.
Publication type:
Article
A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment
Published in:
British Journal of Dermatology, 2020, v. 182, n. 4, p. 869, doi. 10.1111/bjd.18384
By:
- Reich, K.;
- Augustin, M.;
- Thaçi, D.;
- Pinter, A.;
- Leutz, A.;
- Henneges, C.;
- Schneider, E.;
- Schacht, A.;
- Dossenbach, M.;
- Mrowietz, U.
Publication type:
Article
A study of the drug tildrakizumab in psoriasis patients.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 3, p. e100, doi. 10.1111/bjd.18831
By:
- Reich, K.;
- Warren, R.B.;
- Iversen, L.;
- Puig, L.;
- Pau‐Charles, I.;
- Igarashi, A.;
- Ohtsuki, M.;
- Falqués, M.;
- Harmut, M.;
- Rozzo, S.;
- Lebwohl, M.G.;
- Cantrell, W.;
- Blauvelt, A.;
- Thaçi, D.
Publication type:
Article
一项在银屑病患者中开展的 tildrakizumab 药物研究.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 3, p. e113, doi. 10.1111/bjd.18844
By:
- Reich, K.;
- Warren, R.B.;
- Iversen, L.;
- Puig, L.;
- Pau‐Charles, I.;
- Igarashi, A.;
- Ohtsuki, M.;
- Falqués, M.;
- Harmut, M.;
- Rozzo, S.;
- Lebwohl, M.G.;
- Cantrell, W.;
- Blauvelt, A.;
- Thaçi, D.
Publication type:
Article
Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 3, p. 605, doi. 10.1111/bjd.18232
By:
- Reich, K.;
- Warren, R.B.;
- Iversen, L.;
- Puig, L.;
- Pau‐Charles, I.;
- Igarashi, A.;
- Ohtsuki, M.;
- Falqués, M.;
- Harmut, M.;
- Rozzo, S.;
- Lebwohl, M.G.;
- Cantrell, W.;
- Blauvelt, A.;
- Thaçi, D.
Publication type:
Article
一项关于 dupilumab 治疗湿疹青少年患者的研究.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 1, p. e47, doi. 10.1111/bjd.18678
By:
- Cork, M.J.;
- Thaçi, D.;
- Eichenfield, L.F.;
- Arkwright, P.D.;
- Hultsch, T.;
- Davis, J.D.;
- Zhang, Y.;
- Zhu, X.;
- Chen, Z.;
- Li, M.;
- Ardeleanu, M.;
- Teper, A.;
- Akinlade, B.;
- Gadkari, A.;
- Eckert, L.;
- Kamal, M.A.;
- Ruddy, M.;
- Graham, N.M.H.;
- Pirozzi, G.;
- Stahl, N.
Publication type:
Article
A study of dupilumab in the treatment of adolescents with eczema.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 1, p. e30, doi. 10.1111/bjd.18661
By:
- Cork, M.J.;
- Thaçi, D.;
- Eichenfield, L.F.;
- Arkwright, P.D.;
- Hultsch, T.;
- Davis, J.D.;
- Zhang, Y.;
- Zhu, X.;
- Chen, Z.;
- Li, M.;
- Ardeleanu, M.;
- Teper, A.;
- Akinlade, B.;
- Gadkari, A.;
- Eckert, L.;
- Kamal, M.A.;
- Ruddy, M.;
- Graham, N.M.H.;
- Pirozzi, G.;
- Stahl, N.
Publication type:
Article
Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension.
Published in:
British Journal of Dermatology, 2020, v. 182, n. 1, p. 85, doi. 10.1111/bjd.18476
By:
- Cork, M.J.;
- Thaçi, D.;
- Eichenfield, L.F.;
- Arkwright, P.D.;
- Hultsch, T.;
- Davis, J.D.;
- Zhang, Y.;
- Zhu, X.;
- Chen, Z.;
- Li, M.;
- Ardeleanu, M.;
- Teper, A.;
- Akinlade, B.;
- Gadkari, A.;
- Eckert, L.;
- Kamal, M.A.;
- Ruddy, M.;
- Graham, N.M.H.;
- Pirozzi, G.;
- Stahl, N.
Publication type:
Article
Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study.
Published in:
British Journal of Dermatology, 2019, v. 181, n. 6, p. 1177, doi. 10.1111/bjd.18029
By:
- Thaçi, D.;
- Papp, K.;
- Marcoux, D.;
- Weibel, L.;
- Pinter, A.;
- Ghislain, P.‐D.;
- Landells, I.;
- Hoeger, P.H.;
- Unnebrink, K.;
- Seyger, M.M.B.;
- Williams, D.A.;
- Rubant, S.;
- Philipp, S.
Publication type:
Article
Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis.
Published in:
British Journal of Dermatology, 2019, v. 181, n. 6, p. 1254, doi. 10.1111/bjd.17989
By:
- Langan, E.A.;
- Künstner, A.;
- Miodovnik, M.;
- Zillikens, D.;
- Thaçi, D.;
- Baines, J.F.;
- Ibrahim, S.M.;
- Solbach, W.;
- Knobloch, J.K.
Publication type:
Article
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.
Published in:
British Journal of Dermatology, 2019, v. 181, n. 1, p. 80, doi. 10.1111/bjd.17791
By:
- Silverberg, J.I.;
- Simpson, E.L.;
- Ardeleanu, M.;
- Thaçi, D.;
- Barbarot, S.;
- Bagel, J.;
- Chen, Z.;
- Eckert, L.;
- Chao, J.;
- Korotzer, A.;
- Rizova, E.;
- Rossi, A.B.;
- Lu, Y.;
- Graham, N.M.H.;
- Hultsch, T.;
- Pirozzi, G.;
- Akinlade, B.
Publication type:
Article

Found: 77